Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 12, 2007, Pages 1460-1465

  Burnat, Grzegorz ^a   Rau, Tilman ^a   Elshimi, Esam ^a   Hahn, Eckhart Georg ^a   Konturek, Peter Christopher ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Barrett's esophagus; Bile acids; CDX 2

Indexed keywords

BILE ACID; BILE SALT; DEOXYCHOLIC ACID; MESSENGER RNA; TRANSCRIPTION FACTOR CDX2; URSODEOXYCHOLIC ACID; VASCULOTROPIN;

ACIDIFICATION; ADENOCARCINOMA; ANALYTIC METHOD; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS EPITHELIUM; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; ANALYSIS OF VARIANCE; BARRETT ESOPHAGUS; BILE ACIDS AND SALTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 36249001678     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520701452209     Document Type: Article

References (21)

1. Cameron AJ, Lomboy CT. Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 1992;103:1241-5.
2. Bonino JA, Sharma P. Barrett's esophagus. Curr Opin Gastroenterol 2005;21:461-5.
3. Fitzgerald RC. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation? Gut 2005;54 Suppl 1:i21-6.
4. Jankowski JA, Harrison RF, Perry I, Balkwill F, Tselepis C. Barrett's metaplasia. Lancet 2000;356:2079-85.
5. Fein M, Maroske J, Fuchs KH. Importance of duodenogastric reflux in gastro-oesophageal reflux disease. Br J Surg 2006;93:1475-82.
6. Kaur BS, Triadafilopoulos G. Acid- and bile-induced PGE(2) release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-epsilon dependent. Am J Physiol Gastrointest Liver Physiol 2002;283:G327-34.
7. Guo RJ, Suh ER, Lynch JP. The role of Cdx proteins in intestinal development and cancer. Cancer Biol Ther 2004;3:593-601.
8. Moons LM, Bax DA, Kuipers EJ, Van Dekken H, Haringsma J, Van Vliet AH, et al. The homeodomain protein CDX2 is an early marker of Barrett's oesophagus. J Clin Pathol 2004;57:1063-8.
9. Silberg DG, Sullivan J, Kang E, Swain GP, Moffett J, et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 2002;122:689-96.
10. Kazumori H, Ishihara S, Rumi MA, Kadowaki Y, Kinoshita Y. Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium. Gut 2006;55:16-25.
11. Tonra JR, Hicklin DJ. Targeting the vascular endothelial growth factor pathway in the treatment of human malignancy. Immunol Invest 2007;36:3-23.
12. Zhong H, Bowen JP. Antiangiogenesis drug design: multiple pathways targeting tumor vasculature. Curr Med Chem 2006;13:849-62.
13. Harrison RF, Perry I, Jankowski JA. Barrett's mucosa: remodelling by the microenvironment. J Pathol 2000;192:1-3.
14. Couvelard A, Paraf F, Gratio V, Scoazec JY, Henin D, Degott C, et al. Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression. J Pathol 2000;192:14-8.
15. Jenkins GJ, Harries K, Doak SH, Wilmes A, Griffith AP, Baxter JN, et al. The bile acid deoxycholic acid at neutral pH activates NF. kappaB and induces IL-8 expression in esophageal cells in vitro. Carcinogenesis 2004;25:317-23.
16. Phillips RW, Frierson HF Jr, Moskaluk CA. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol 2003;27:1442-7.
17. Todd JA, Basu KK, de Caestecker JS. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus. Aliment Pharmacol Ther 2005;21:969-75.
18. Konturek PC, Burnat G, Hahn EG. Bile salts induce COX-2 expression in Barrett adenocarcinoma cells via stimulation of NFkB [abstract I-P-14-83]. Digestion 2006;73 Suppl 2:49.
19. Dvorak K, Payne CM, Chavarria M, Ramsey L, Dvorakova B, Bernstein H, et al. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut 2007;56:763-71.
20. Mobius C, Stein HJ, Becker I, Feith M, Theisen J, Gais P, et al. The "angiogenic switch" in the progression from Barrett's metaplasia to esophageal adenocarcinoma. Eur J Surg Oncol 2003;29:890-4.
21. Wali RK, Stoiber D, Nguyen L, Hart J, Sitrin MD, Brasitus T, et al. Ursodeoxycholic acid inhibits the initiation and post-initiation phases of azoxymethane-induced colonic tumor development. Cancer Epidemiol Biomarkers Prev 2002;11:1316-21.